You are now leaving the Viatris Netherlands website and going to an affiliated Viatris website or a third-party website that is solely responsible for its content, including compliance with guidelines applicable in certain regions. Links to affiliated Viatris websites and third-party websites are provided as a resource for our visitors and may not be subject to the same legal requirements applicable to this website; unaffiliated third-party websites are subject to their own terms, notices, and data protection practices. Additionally, the third-party website may be subject to different local laws, and legal requirements, data protection requirements, or medical practices may vary from country to country. Therefore, the information provided may not be suitable for use in your country.
Unified by their commitment to helping patients address their evolving healthcare needs, our industry-leading team of executives and board members will guide Viatris into the future of global healthcare.
Scott A. Smith
Chief Executive Officer
Viatris chief executive officer Scott A. Smith is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with more than 35 years of experience. He is a seasoned builder who possesses vast global commercial and pharmaceutical expertise and a proven ability to build, grow and manage large complex organizations. Before becoming Viatris’ CEO, Smith was President and Chief Operating Officer of Celgene Corp. Most recently, he served as President of BioAtla, Inc., a global biotechnology company focused on the development of Conditionally Active BiologicsTM (CAB) antibody therapeutics. Smith is a member of Viatris board of directors.
